News

Eloxx Pharmaceuticals Announces Changes to Board of Directors

Lindsay Androski, JD, MBA brings significant experience growing biotech companies through her roles as an executive at Roivant Social Ventures…

2 years ago

Chinook Therapeutics Receives Orphan Drug Designation from European Commission for BION-1301 for Treatment of Primary IgA Nephropathy (IgAN)

SEATTLE, July 05, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development…

2 years ago

Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US for Its Lead Clinical Development Program – Ketamine-Assisted Therapy for Alcohol Use Disorder

Awakn Provides Business Update on Progressing its Lead Program from Phase II b to Phase IIIToronto, Ontario--(Newsfile Corp. - July…

2 years ago

Perspectum Announces American Medical Association (AMA) Issues Two Unique Category III CPT® Codes Priced Appropriately by the Centers for Medicare & Medicaid Services (CMS) for Noninvasive Biliary Anatomy Assessment With MRCP+

DALLAS--(BUSINESS WIRE)--#Healthcare--The American Medical Association (AMA) has issued two unique Category III Current Procedural Terminology (CPT®) codes for Quantitative Magnetic…

2 years ago

Two-part Study Finds That Remote Patient Monitoring with Masimo SafetyNet® Reduced Length of Hospital Stay for COVID-19 Patients

New Study Evaluates Masimo SafetyNet in Helping Patients Recover at Home IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings…

2 years ago

Sonendo, Inc. Welcomes Joanne Lindberg as Vice President of Sales, North America

Bringing More Than 20 Years of Experience to Sonendo, Lindberg Will Focus on Accelerating Sales Growth LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo,…

2 years ago

Defence’s Accum(TM) with Antibody Drug Conjugates (ADC) in Development Against Cancer

Vancouver, British Columbia--(Newsfile Corp. - July 5, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"…

2 years ago

AlzeCure Gets Abstract on New Clinical Study Data with NeuroRestore Accepted at the Alzheimer’s Conference AAIC

STOCKHOLM, SWEDEN / ACCESSWIRE / July 5, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical…

2 years ago

Pharnext Appoints Antoine Gravelle as General Counsel

PARIS, FRANCE / ACCESSWIRE / July 5, 2022 / Pharnext SA (FR0011191287-ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company…

2 years ago

Evotec Completes Acquisition of Rigenerand

AS "EVOTEC CELL ACCELERATOR", THE HIGH-QUALITY CGMP CELL THERAPY MANUFACTURING SITE ADDS CAPACITY AND CAPABILITYEVOTEC'S EVO CELLS PLATFORM INTEGRATES INNOVATIVE…

2 years ago